Enter assignee name

CIPO Patents = 2

Forward Citations = 87

Loading Chart...

4 inventors (with patents filed for the assignee):

Neil R Cashman (10 out of 35 patents)

Avijit Chakrabartty (4 out of 18 patents)

Rishi Rakhit (4 out of 8 patents)

4. Joachim Bernhard Ostermann (2 out of 3 patents)

5. Marty Lehto (1 patent)

6. Marty Letho (0 patent)

10 patents: Sort by Forward Citations

1. 8828389 - Methods of diagnosing ALS (2014-09-09),

2. 8778885 - Methods and compositions to treat and detect misfolded-SOD1 mediated diseases (2014-07-15),

3. 8709422 - Methods and compositions to treat and detect misfolded-SOD1 mediated diseases (2014-04-29),

4. 8513387 - Methods and compositions for detecting amyotrophic lateral sclerosis (2013-08-20),

5. 8075891 - Antibodies that bind ALS specific epitopes and methods of making (2011-12-13),

6. 7977314 - Methods and compositions to treat and detect misfolded-SOD1 mediated diseases (2011-07-12),

7. 7887803 - Methods and compositions to treat misfolded-SOD1 mediated diseases (2011-02-15),

8. 7794692 - Methods and compositions for detecting amyotrophic lateral sclerosis (2010-09-14),

9. 7763710 - ALS-specific peptide composition (2010-07-27),

10. 7439324 - ALS-specific peptide composition (2008-10-21),

Amorfix Life Sciences Limited is a biotechnology company focused on the development and commercialization of novel diagnostics and therapeutics for neurological diseases. The company's proprietary technology platform, ProMIS™, enables the identification of disease-specific epitopes for the development of targeted treatments. Amorfix is committed to advancing innovative solutions that address the unmet medical needs of patients with neurodegenerative disorders.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

10 Patents

#1 in Toronto, ON

#1,468 in unknown

#54,324 in the World

Toronto, ON, undefined

Amorfix Life Sciences Limited